These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16312463)
21. Development of antibiotic resistance: a vet's tale. Wray C J Med Microbiol; 1997 Jan; 46(1):26-33. PubMed ID: 9003742 [No Abstract] [Full Text] [Related]
22. Probiotics in man and animals. Fuller R J Appl Bacteriol; 1989 May; 66(5):365-78. PubMed ID: 2666378 [TBL] [Abstract][Full Text] [Related]
23. Battle-hardened bacteria. Park A Time; 2007 Jun; 169(25):59-60. PubMed ID: 18655541 [No Abstract] [Full Text] [Related]
24. Novel approach to combating superbugs. Johnston N Drug Discov Today; 2005 Feb; 10(3):163-4. PubMed ID: 15708526 [No Abstract] [Full Text] [Related]
25. Who or what is the source of antibiotic resistance? Bergogne-Bérézin E J Med Microbiol; 1997 Jun; 46(6):461-4. PubMed ID: 9379476 [No Abstract] [Full Text] [Related]
30. The biological cost of mutational antibiotic resistance: any practical conclusions? Andersson DI Curr Opin Microbiol; 2006 Oct; 9(5):461-5. PubMed ID: 16890008 [TBL] [Abstract][Full Text] [Related]
31. [Experimental chemotherapy]. Prát V Cas Lek Cesk; 1972 Nov; 111(45):1053-4. PubMed ID: 5084851 [No Abstract] [Full Text] [Related]
32. Bacterial cell division as a target for new antibiotics. Sass P; Brötz-Oesterhelt H Curr Opin Microbiol; 2013 Oct; 16(5):522-30. PubMed ID: 23932516 [TBL] [Abstract][Full Text] [Related]
33. [Systemic antibiotics in the treatment of periodontitis]. American Academy of Periodontology Ned Tijdschr Tandheelkd; 1997 Aug; 104(8):291-7; discussion 298-9. PubMed ID: 11924413 [No Abstract] [Full Text] [Related]
35. Global resistance trends and the potential impact on empirical therapy. Isturiz R Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S201-6. PubMed ID: 19134520 [TBL] [Abstract][Full Text] [Related]
36. Will fluoroquinolones ever be recommended for common infections in children? Schaad UB Pediatr Infect Dis J; 2007 Oct; 26(10):865-7. PubMed ID: 17901790 [No Abstract] [Full Text] [Related]
37. An infectious disease update on antibiotics: emerging resistance. Steinberg JS; Kim PJ; Abbruzzese MR Clin Podiatr Med Surg; 2007 Apr; 24(2):285-309. PubMed ID: 17430771 [TBL] [Abstract][Full Text] [Related]
38. Selecting therapeutic concentrations: minimum inhibitory concentrations vs subminimum or supraminimum inhibitory concentrations. Powers TE; Varma KJ; Powers JD J Am Vet Med Assoc; 1984 Nov; 185(10):1062-7. PubMed ID: 6392231 [No Abstract] [Full Text] [Related]
39. Antibiotic and antifungal resistance in antibiotic "free" environment? Krcmery V; Kalavsky E Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():33-4. PubMed ID: 18030277 [No Abstract] [Full Text] [Related]
40. Pharmacodynamics and the prediction of efficacy in short-course antibiotic therapy: pediatric studies to validate the model. Bradley JS Pharmacotherapy; 2005 Dec; 25(12 Pt 2):159S-164S. PubMed ID: 16305287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]